Department of Gastroenterology, Hangzhou Third People’s Hospital, No. 38 West Lake Road, Hangzhou 310000, Zhejiang Province, China
Case Report
Autoimmune-Like Drug-Induced Liver Injury caused by Fenofibrate, Atorvastatin and Ezetimibe: A Case Report
Author(s): Kejie Hu*, Yufang Wang, Yahong He and Jiabin Xiong
In recent years, Drug-Induced Liver Injury (DILI) has become a significant concern due to its potential for severe
liver damage. We present a case report of autoimmune-like DILI caused by the concomitant use of fenofibrate,
atorvastatin and ezetimibe. Glucocorticoid therapy has been proven to be effective. The patient was monitored for
an additional 3 years and no changes were observed. Additionally, we provide a comprehensive literature review on
similar cases to enhance our understanding of this rare adverse drug reaction. This case highlights the importance
of considering autoimmune-like DILI as a potential diagnosis in patients presenting with liver injury and positive
autoantibodies. Healthcare professionals should be aware of the potential hepatotoxicity associated with fenofibrate,
atorvastatin and ezetimibe. Early recognition and prompt withdrawal of the o.. View More»
DOI:
10.35248/IGOA.24.9.222